Award
NIH Reporter #3R01CA263806-05S1
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
Recipient
Not specified
Award Amount
$82,514.00
Ceiling
$82,514.00
Awarded
August 25, 2025
Identifier
3R01CA263806-05S1
Research project funded by the National Cancer Institute to develop treatments mitigating cisplatin-induced neurotoxicity, focusing on p38 and JNK MAPK pathways, with a focus on female mice models.
Description
The project aims to develop therapeutics to reduce cisplatin-induced neurotoxic side effects, focusing on p38 MAPK and JNK pathways. The study involves in vitro analysis, behavioral testing, and gait analysis in female mice. The research emphasizes the importance of testing in female models due to health disparities.